| Revenue | NOK 0 | — |
| EBITDA | NOK -9K | +30% |
| Net profit | NOK -10K | +27% |
| Total assets | NOK 1K | +29% |
| Equity | NOK -4K | -451% |
| Employees | 0 | — |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −18 | −12 | −13 | −9 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −18 | −12 | −13 | −9 |
| Net financials | 0 | 0 | 0 | 0 | −0 |
| Profit before tax | −6 | −18 | −12 | −13 | −10 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | −18 | −12 | −13 | −10 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 994 | 26 | 14 | 1 | 1 |
| Equity | 4 994 | 26 | 14 | 1 | −4 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 5 |
| Total debt | 0 | 0 | 0 | 0 | 5 |
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Puravida Holding As | Company | 20.0% | 20.0% | 2024 |
Ebbell-Tidemann Invest As | Company | 20.0% | 20.0% | 2024 |
Asec Holding As | Company | 20.0% | 20.0% | 2024 |
Canju As | Company | 20.0% | 20.0% | 2024 |
Biodiner Kapital As | Company | 20.0% | 20.0% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Torbjørn Emil Ebbell Tidemann | Board of Directors | 0 companies |
| Daniel Andreas Stockhausen Hektoen | Board of Directors | 0 companies |
| Rune Fagermoen | Chairman | 0 companies |
| Asle Stenvaagnes | Board of Directors | 0 companies |
| Johan Vik | Board of Directors | 0 companies |